Education
About Us
Working with TipRanks
Follow Us
Harrow Health Inc (HROW)
NASDAQ:HROW
Total Valuation
Harrow Health has a market cap or net worth of $1.47B. The enterprise value is $2.05B.
Market Cap$1.47B
Enterprise Value$2.05B
Share Statistics
Harrow Health has 37,037,453 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding37,037,453
Owned by Insiders26.45%
Owned by Institutions25.22%
Financial Efficiency
Harrow Health’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is 2.99%.
Return on Equity (ROE)-0.25
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)2.99%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee522.55K
Profits Per Employee-45.76K
Employee Count382
Asset Turnover0.51
Inventory Turnover4.60
Valuation Ratios
The current PE Ratio of Harrow Health is ―. Harrow Health’s PEG ratio is 1.97.
PE Ratio―
PS Ratio5.99
PB Ratio17.17
Price to Fair Value17.17
Price to FCF-19.65
Price to Operating Cash Flow367.17
PEG Ratio1.97
Income Statement
In the last 12 months, Harrow Health had revenue of 199.61M and earned -17.48M in profits. Earnings per share was -0.49.
Revenue199.61M
Gross Profit150.37M
Operating Income8.82M
Pretax Income-17.32M
Net Income-17.48M
EBITDA22.13M
Earnings Per Share (EPS)-0.49
Cash Flow
In the last 12 months, operating cash flow was 17.67M and capital expenditures -38.15M, giving a free cash flow of -20.47M billion.
Operating Cash Flow17.67M
Free Cash Flow-20.47M
Free Cash Flow per Share-0.55
Dividends & Yields
Harrow Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.11
52-Week Price Change-12.21%
50-Day Moving Average40.80
200-Day Moving Average32.72
Relative Strength Index (RSI)46.84
Average Volume (3m)750.90K
Important Dates
Harrow Health upcoming earnings date is Mar 25, 2026, After Close (Confirmed).
Last Earnings DateNov 10, 2025
Next Earnings DateMar 25, 2026
Ex-Dividend Date―
Financial Position
Harrow Health as a current ratio of 2.08, with Debt / Equity ratio of 465.72%
Current Ratio2.08
Quick Ratio1.96
Debt to Market Cap0.18
Net Debt to EBITDA9.42
Interest Coverage Ratio0.39
Taxes
In the past 12 months, Harrow Health has paid 161.00K in taxes.
Income Tax161.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Harrow Health EV to EBITDA ratio is 71.45, with an EV/FCF ratio of -22.63.
EV to Sales6.90
EV to EBITDA71.45
EV to Free Cash Flow-22.63
EV to Operating Cash Flow-62.05
Balance Sheet
Harrow Health has $74.29M in cash and marketable securities with $251.87M in debt, giving a net cash position of -$177.58M billion.
Cash & Marketable Securities$74.29M
Total Debt$251.87M
Net Cash-$177.58M
Net Cash Per Share-$4.79
Tangible Book Value Per Share-$3.30
Margins
Gross margin is 74.56%, with operating margin of 4.42%, and net profit margin of -8.76%.
Gross Margin74.56%
Operating Margin4.42%
Pretax Margin-8.68%
Net Profit Margin-8.76%
EBITDA Margin9.66%
EBIT Margin2.38%
Analyst Forecast
The average price target for Harrow Health is $72.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$72.67
Price Target Upside92.96% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast47.83%
EPS Growth Forecast84.72%